J Cancer 2022; 13(3):1031-1047. doi:10.7150/jca.56777 This issue Cite

Research Paper

The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma

Jing Zhang1, Xin-Wei Chen2, Li-Sha Shu3, Chong-Dong Liu1✉

1. Department of gynecology and obstetrics, Chao Yang Hospital of Capital Medical University, Beijing,100020, China
2. Department of blood transfusion, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China
3. Department of gynecology and obstetrics, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China

Citation:
Zhang J, Chen XW, Shu LS, Liu CD. The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. J Cancer 2022; 13(3):1031-1047. doi:10.7150/jca.56777. https://www.jcancer.org/v13p1031.htm
Other styles

File import instruction

Abstract

Graphic abstract

Background: SLC30 family genes, also known as ZnT family genes, can keep cellular zinc levels within a physiological range by exporting zinc to extracellular space or by isolating zinc in the specific regions of cytoplasm when cellular zinc concentrations are elevated in human cells. There are growing evidences that dysregulated expression of SLC30 family genes can potentially influence tumorigenesis. However, the expression and prognostic value of SLC30 family genes in cervical carcinoma are poorly characterized.

Methods: In this study, we used many tools such as UALCAN, Kaplan-Meier Plotter, cBioPortal, LinkedOmics, FunRich, Metascape, GeneMANIA, Open targets and TISIDB to perform bioinformatics analysis of SLC30 family genes in cervical carcinoma.

Results: We found that the expression of SLC30A1/7/10 was significantly higher in cervical carcinoma than that in normal matched tissues, while SLC30A2/8 mRNA levels were decreased compared to normal tissues. For tumor stages, SLC30A1, SLC30A7 and SLC30A10 groups significantly varied. And a high expression of SLC30A1, SLC30A6, SLC30A8 and SLC30A10 was associated with worse overall survival in cervical carcinoma patients. Besides, we found that SLC30A1/10 may have a potential regulatory role in immune infiltration in cervical carcinoma. In addition, the results showed that the high expression of SLC30A1 was resistant to 79 drugs or small molecules; Two drugs (Neopeltolide and Tozasertib) can inhibit the high expression of SLC30A10 in cancers.

Conclusion: SLC30A1 and SLC30A10 can be recognized as potential diagnostic indicators and therapeutic targets in cervical carcinoma.

Keywords: cervical carcinoma, SLC30A1, SLC30A10, microenvironment


Citation styles

APA
Zhang, J., Chen, X.W., Shu, L.S., Liu, C.D. (2022). The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. Journal of Cancer, 13(3), 1031-1047. https://doi.org/10.7150/jca.56777.

ACS
Zhang, J.; Chen, X.W.; Shu, L.S.; Liu, C.D. The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. J. Cancer 2022, 13 (3), 1031-1047. DOI: 10.7150/jca.56777.

NLM
Zhang J, Chen XW, Shu LS, Liu CD. The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. J Cancer 2022; 13(3):1031-1047. doi:10.7150/jca.56777. https://www.jcancer.org/v13p1031.htm

CSE
Zhang J, Chen XW, Shu LS, Liu CD. 2022. The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. J Cancer. 13(3):1031-1047.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.